| Geoffrey Howard Rosen, MD | |
|
1 Hospital Dr # Mc404, Columbia, MO 65212-1000 | |
| (573) 884-2000 | |
| (573) 884-4611 |
| Full Name | Geoffrey Howard Rosen |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1 Hospital Dr # Mc404, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679066823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2018018333 (Missouri) | Secondary |
| 208800000X | Urology | 2019023349 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Geoffrey Howard Rosen, MD 1 Hospital Dr # Mc404, Columbia, MO 65212-1000 Ph: (573) 884-2000 | Geoffrey Howard Rosen, MD 1 Hospital Dr # Mc404, Columbia, MO 65212-1000 Ph: (573) 884-2000 |
News Archive
Johns Hopkins researchers say there is growing evidence that stem cells gone awry in their efforts to repair tissue damage could help explain why long-term irritation, such as from alcohol or heartburn, can create a breeding ground for certain cancers.
Merck KGaA, Darmstadt, Germany, today announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC).
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the publication of a study of the metabolic effects of its drug candidate, Bezielle, on cancer cells in the International Journal of Cancer.
New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.
› Verified 8 days ago
Michael Cupp, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 105 N Keene St, Ste 201, Columbia, MO 65201 Phone: 573-499-4990 Fax: 573-442-2120 | |
Elizabeth Ashiokor Malm-buatsi, M.D. Urology Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-817-3311 Fax: 573-499-6395 | |
Dr. Naveen Pokala, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-884-8768 Fax: 573-884-7453 | |
Eliza Lamin Defroda, MD Urology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-884-8538 Fax: 573-884-7453 | |
Emma Libby, MD Urology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-1771 | |
Garth Sherman, MD Urology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr # Mc301, Columbia, MO 65201 Phone: 573-882-1771 | |
Kimberly Marie Kocour, MD Urology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-1771 |